Insider Transactions in Q3 2023 at Yumanity Therapeutics, Inc. (YMTX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2023
|
Craig W. Philips President and Secretary |
BUY
Open market or private purchase
|
Direct |
2,900
+4.78%
|
$5,800
$2.4 P/Share
|
|
Sep 20
2023
|
Shawn Iadonato |
BUY
Open market or private purchase
|
Direct |
10,000
+1.47%
|
$20,000
$2.5 P/Share
|
|
Sep 20
2023
|
Pauline Kenny General Counsel & Secretary |
BUY
Open market or private purchase
|
Direct |
1,500
+7.52%
|
$3,000
$2.58 P/Share
|
|
Sep 20
2023
|
Craig W. Philips President and Secretary |
BUY
Open market or private purchase
|
Direct |
600
+1.08%
|
$1,200
$2.54 P/Share
|
|
Sep 19
2023
|
Raymond J. Bartoszek |
BUY
Open market or private purchase
|
Direct |
2,000
+11.8%
|
$4,000
$2.37 P/Share
|
|
Sep 18
2023
|
Raymond J. Bartoszek |
BUY
Open market or private purchase
|
Direct |
2,500
+16.17%
|
$5,000
$2.08 P/Share
|
|
Sep 18
2023
|
Keith Baker Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+22.85%
|
$10,000
$2.13 P/Share
|
|
Sep 15
2023
|
Raymond J. Bartoszek |
BUY
Open market or private purchase
|
Direct |
500
+4.56%
|
$1,000
$2.18 P/Share
|
|
Sep 14
2023
|
Thierry Guillaudeux Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+31.55%
|
$20,000
$2.0 P/Share
|